Breaking News2 years ago
ASCO: Luspatercept enables majority of patients with MDS to end reliance on blood transfusions
[ad_1] ABSTRACT: 7003 Treatment with luspatercept improved red blood cell counts and erythroid responses compared to treatment with epoetin alfa in patients with myelodysplastic syndromes (MDS),...